Поиск
Закладки
Озвучить текст Озвучить книгу
Изменить режим чтения
Изменить размер шрифта
Оглавление
Для озвучивания и цитирования книги перейдите в режим постраничного просмотра.
Ожирение

Список литературы

  1. World Health Organization. Obesity: preventing and managing the global epidemic. 1997, Geneva: WHO.
  2. Biddle S, García Bengoechea E, Pedisic Z, et al. Screen Time, Other Sedentary Behaviours, and Obesity Risk in Adults: A Review of Reviews. Curr Obes Rep. 2017; 6(2):134-147.
  3. Arroyo-Johnson C, Mincey KD. Obesity Epidemiology Worldwide. Gastroenterol Clin North Am. 2016; 45(4): 571-579.
  4. Heymsfield SB, Wadden TA. Mechanisms, Pathophysiology, and Management of Obesity. N Engl J Med. 2017; 376(3): 254-266.
  5. Yeo G., Heisler L. Unraveling the brain regulation of appetite: lessons from genetics. Nat Neurosci. 2012; 15 (10): 1343–1349.
  6. Lam D., Garfield A., Marston O. et al. Brain serotonin system in the coordination of food intake and body weight. Pharmacol Biochem Behav. 2010; 97 (1): 84–91.
  7. Campbell E, Franks A, Joseph P. Adolescent obesity in the past decade: A systematic review of genetics and determinants of food choice. J Am Assoc Nurse Pract. 2019; 31(6): 344-351.
  8. Zhi C, Huang J, Wang J, et al. Connection between gut microbiome and the development of obesity. Eur J Clin Microbiol Infect Dis. 2019; Jul 31. doi: 10.1007/s10096-019-03623-x.
  9. Kadowaki T, et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest. 2006; 116: 1784-1792.
  10. Bastard J, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006 Mar;17(1):4-12.
  11. Montanari T, Pošćić N, Colitti M. Factors involved in white-to-brown adipose tissue conversion and in thermogenesis: a review. Obes Rev. 2017; 18(5):495-513.
  12. Fernández-Verdejo R, Marlatt K, Ravussin E, Galgani J. Contribution of brown adipose tissue to human energy metabolism. Mol Aspects Med. 2019 Jul 16. pii: S0098-2997(19)30029-9. doi: 10.1016/j.mam.2019.07.003
  13. Must A., Spadano J., Coakley E. et al. The disease burden associated with overweight and obesity. JAMA 1999, 282, 1523-1529.
  14. Guh D., Zhang W., Bansback N. et al. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009; 9: 88.
  15. Lenz M., Richter T., Muhlhauser I. The morbidity and mortality associated with overweight and obesity in adulthood: a systematic review. Dtsch Arztebl Int 2009; 106: 641-648.
  16. Alberti K, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus Group. The metabolic syndrome a new worldwide definition. Lancet. 2005; 366: 1059-62.
  17. (WHO (2020), Obesity and overweight, https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight).
  18. Kelly T, Yang W, Chen CS, et al. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond). 2008 Sep;32(9):1431-7.
  19. Дедов И.И., Шестакова М.В., Галстян Г.Р. Распространенность сахарного диабета 2 типа у взрослого населения России (исследование NATION). Сахарный диабет. 2016;19(2):104-112
  20. https://www.rospotrebnadzor.ru/documents/details.php?ELEMENT_ID=14933
  21. OECD (2021), Overweight or obese population (indicator). doi:10.1787/86583552-en (Accessed on 28 August 2021)
  22. Баланова Ю. А., Шальнова С. А., Деев А. Д. и др. Ожирение в российской популяции — распространенность и ассоциации с факторами риска хронических неинфекционных заболеваний. Российский кардиологический журнал. 2018;(6):123-30. doi:10.15829/1560-4071-2018-6-123-130).
  23. Garvey W, Garber A, Mechanick J, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Position Statement on the 2014 Advanced Framework for a New Diagnosis of Obesity as a Chronic Disease. Endocr Pract. 2014; 20: 977-989.
  24. Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. Geneva, World Health Organization, 1995 (Technical Report Series, No. 854):329.
  25. Kuczmarski RJ et al. Increasing prevalence of overweight among US adults. The National Health and Nutrition Examination Surveys, 1960 to 1991.Journal of the American Medical Association, 1994, 272:205-211.
  26. Swinburn BA et al. Body composition differences between Polynesians and Caucasians assessed by bioelectrical impedance. International Journal of Obesity and Related Metabolic Disorders, 1996, 20:889-894.
  27. Forbes GB, Reina JC. Adult lean body mass decline with age: some longitudinal observations. Metabolism: Clinical and Experimental, 1970, 19:653-663.
  28. Rolland-Cachera MF et al. Body mass index variations - centiles from birth to 87 years. European Journal of Clinical Nutrition, 1991, 45:13-21.
  29. Ross R et al. Sex differences in lean and adipose tissue distribution by magnetic resonance imaging: anthropometric relationships. American Journal of Clinical Nutrition, 1994, 59:1277-1285.
  30. Norgan NG, Jones PRM. The effect of standardizing the body mass index for relative sitting height. International Journal of Obesity and Related Metabolic Disorders, 1995, 19:206-208.
  31. Lean MEJ, Han TS, Morrison CE. Waist circumference as a measure for indicating need for weight management. British Medical Journal, 1995, 311:158-161.
  32. Han TS et al. Waist circumference relates to intra-abdominal fat mass better than waist:hip ratio in women. Proceedings of the Nutrition Society, 1995, 54:152A.
  33. Pouliot MC et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. American Journal of Cardiology, 1994, 73:460-468.
  34. Ross R et al. Quantification of adipose tissue by MRI: relationship with anthropometric variables. Journal of Applied Physiology, 1992, 72:787-795.
  35. Lean MEJ, Han TS, Deurenberg P. Predicting body composition by densitometry from simple anthropometric measurements. American Journal of Clinical Nutrition, 1996, 63:4-14.
  36. Han TS et al. Waist circumference reduction and cardiovascular benefits during weight loss in women. International Journal of Obesity and Related Metabolic Disorders, 1997, 21: 127-134.
  37. Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011; 377(9765): 557-567.
  38. Wormser D, et al. Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet. 2011; 377(9771):1085–95.
  39. Nishida C, Barba C, Cavalli-Sforza T, et al. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363(9403):157-163. doi: https://doi.org/10.1016/S0140-6736(03)15268-3
  40. Pan W-H, Yeh W-T. How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations. Asia Pac J Clin Nutr. 2008. doi: https://doi.org/10.6133/apjcn.2008.17.3.02
  41. Nam GE, Park HS. Perspective on Diagnostic Criteria for Obesity and Abdominal Obesity in Korean Adults. J Obes Metab Syndr. 2018;27(3):134-142. doi: https://doi.org/10.7570/jomes.2018.27.3.134
  42. Zeng Q, He Y, Dong S, et al. Optimal cut-off values of BMI, waist circumference and waist:height ratio for defining obesity in Chinese adults. Br J Nutr. 2014;112(10):1735-1744. doi: https://doi.org/10.1017/S0007114514002657
  43. Jih J, Mukherjea A, Vittinghoff E, et al. Using appropriate body mass index cut points for overweight and obesity among Asian Americans. Prev Med (Baltim). 2014;65:1-6. doi: https://doi.org/10.1016/j.ypmed.2014.04.010
  44. Garvey WT, Mechanick JI, Brett EM, et al. Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. EndocrPract. 2016;22(3):1-203. doi: https://doi.org/10.4158/EP161365
  45. Mancia G, De Backer G, Dominiczak A, Cifkova R, et al. ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens. 2007 25(9):1751-62. doi: 10.1097/HJH.0b013e3282f0580f.
  46. Masa J, et al. Obesity hypoventilation syndrome. Eur Respir Rev. 2019 Mar 14; 28(151). pii: 180097.
  47. Macavei V, et al. Diagnostic predictors of obesity-hypoventilation syndrome in patients suspected of having sleep disordered breathing. J Clin Sleep Med 2013; 9: 879–884.
  48. Camilleri M, et al. Gastrointestinal Complications of Obesity. Gastroenterology. 2017 May; 152(7):1656-1670.
  49. Khatua B, et al. Obesity and pancreatitis. Curr Opin Gastroenterol. 2017 Sep;33(5):374-382.
  50. Escobar-Morreale H, et al. Prevalence of 'obesity-associated gonadal dysfunction' in severely obese men and women and its resolution after bariatric surgery: a systematic review and meta-analysis. Hum Reprod Update. 2017 Jul 1;23(4):390-408.
  51. Daniel E, Newell-Price J. Cushing's syndrome. Medicine, Volume 45, Issue 8, 2017, pp. 475-479.
  52. Stuart C, et al. Acanthosis nigricans. J Basic Clin Physiol Pharmacol. 1998; 9(2-4):407-18.
  53. Rohde K, et al. Genetics and epigenetics in obesity. Metabolism. 2019 Mar; 92: 37-50.
  54. Mirzababaei A, et al. Risk of hypertension among different metabolic phenotypes: a systematic review and meta-analysis of prospective cohort studies. J Hum Hypertens. 2019 May; 33(5): 365-377.
  55. Deng G, et al. Associations of anthropometric adiposity indexes with hypertension risk: A systematic review and meta-analysis including PURE-China. Medicine (Baltimore). 2018 Nov; 97(48):e13262.
  56. Biondi B. Thyroid and obesity: an intriguing relationship. Journal of Clinical Endocrinology and Metabolism. 2010; 95: 3614–3617.
  57. Rotondi M, et al. Thyroid and obesity: not a one-way interaction. Journal of Clinical Endocrinology and Metabolism. 2011; 96: 344–346.
  58. Laurberg P, et al. Thyroid function and obesity. European Thyroid Journal. 2012; 1: 159–167.
  59. Pearce E. Thyroid hormone and obesity. Current Opinion in Endocrinology Diabetes and Obesity. 2012; 19: 408–413.
  60. Duntas L, Biondi B. The interconnections between obesity, thyroid function, and autoimmunity: the multifold role of leptin. Thyroid. 2013; 23: 646–653.
  61. Boscaro M, Arnaldi G. Approach to the patient with possible Cushing's syndrome. J Clin Endocrinol Metab. 2009; 94(9): 3121-31.
  62. Auriemma R. The effects of hyperprolactinemia and its control on metabolic diseases. Expert Rev Endocrinol Metab. 2018; 13(2): 99-106.
  63. Santos-Silva C, et al. BMI and metabolic profile in patients with prolactinoma before and after treatment with dopamine agonists. Obesity. 2011; 19: 800–805.
  64. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Report of WHO/IDF Consultation. 2006.
  65. Jiang Z, Wang Y, Zhao X, Cui H, Han M, Ren X, Gang X, Wang G. Obesity and chronic kidney disease. Am J Physiol Endocrinol Metab. 2023 Jan 1;324(1):E24-E41. doi: 10.1152/ajpendo.00179.2022. Epub 2022 Nov 16. PMID: 36383637.
  66. Pereira-Santos M, et al. Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev. 2015; 16(4): 341-349.
  67. Lotito A, et al. Serum Parathyroid Hormone Responses to Vitamin D Supplementation in Overweight/Obese Adults: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Nutrients. 2017; 9(3): pii: E241.
  68. Hjelmesæth J. et al. Parathyroid hormone, but not vitamin D, is associated with the metabolic syndrome in morbidly obese women and men: a cross-sectional study //Cardiovascular diabetology. – 2009. – Т. 8. – №. 1. – С. 7.
  69. Soares M. J. et al. Vitamin D and parathyroid hormone in insulin resistance of abdominal obesity: cause or effect? //European journal of clinical nutrition. – 2011. – Т. 65. – №. 12. – С. 1348-1352.
  70. Silidker M. S. et al. Ultrasound evaluation of cholelithiasis in the morbidly obese //Gastrointestinal radiology. – 1988. – Т. 13. – №. 1. – С. 345-346.
  71. de Moura Almeida A. et al. Fatty liver disease in severe obese patients: diagnostic value of abdominal ultrasound //World journal of gastroenterology: WJG. – 2008. – Т. 14. – №. 9. – С. 1415.
  72. Kapur V, et al. Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med. 2017; 13(3): 479-504.
  73. Bozkurt B, et al. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2016; 134(23): e535-e578.
  74. Ponikowski P, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 37(27): 2129-2200.
  75. Jensen M, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014; 63(25 Pt B): 2985-3023.
  76. Mitchell LJ, Ball LE, Ross LJ, Barnes KA, Williams LT. Effectiveness of Dietetic Consultations in Primary Health Care: A Systematic Review of Randomized Controlled Trials. J Acad Nutr Diet. 2017 Dec;117(12):1941-1962. doi: 10.1016/j.jand.2017.06.364. Epub 2017 Aug 19. PMID: 28826840.
  77. Asikainen TM, Miilunpalo S, Oja P, et al. Randomised, controlled walking trials in postmenopausal women: the minimum dose to improve aerobic fitness? Br J Sports Med. 2002;36(3):189-94.
  78. Poletto J, Rizzo D, Cândido E. et al. The Influence of Physical Activity on Quality of Life in Morbidly Obese Patients with Urinary Dysfunction, Science Journal of Public Health. Special Issue:Obesity and Physical Activity: Myths, Indications and Facts 2020, Volume 8, Issue 3, pp. 72-76
  79. Damirchi A, Tehrani BS, Alamdari KA, Babaei P. Influence of aerobic training and detraining on serum BDNF, insulin resistance, and metabolic risk factors in middle-aged men diagnosed with metabolic syndrome. Clin J Sport Med. 2014 Nov;24(6):513-8. doi: 10.1097/JSM.0000000000000082. PMID: 24662570.
  80. Pattyn N, Cornelissen VA, Eshghi SR, Vanhees L. The effect of exercise on the cardiovascular risk factors constituting the metabolic syndrome: a meta-analysis of controlled trials. Sports Med. 2013 Feb;43(2):121-33. doi: 10.1007/s40279-012-0003-z. PMID: 23329606; PMCID: PMC3693431.
  81. Chazova IE, Shestakova MV, Zhernakova YV, et al. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19(1):41-47. doi: https://doi.org/10.1093/humrep/deh098
  82. International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2018. https://www.monash.edu/medicine/sphpm/mchri/pcos/guideline
  83. Corona G, Goulis DG, Huhtaniemi I, Zitzmann M, Toppari J, Forti G, Vanderschueren D, Wu FC. European Academy of Andrology (EAA) guidelines on investigation, treatment and monitoring of functional hypogonadism in males: Endorsing organization: European Society of Endocrinology. Andrology. 2020 Sep;8(5):970-987. doi: 10.1111/andr.12770. Epub 2020 Mar 20. PMID: 32026626.
  84. Fernandez CJ, Chacko EC, Pappachan JM. Male Obesity-related Secondary Hypogonadism - Pathophysiology, Clinical Implications and Management. Eur Endocrinol. 2019 Aug;15(2):83-90. doi: 10.17925/EE.2019.15.2.83. Epub 2019 Aug 16. PMID: 31616498; PMCID: PMC6785957.
  85. Gerlach G., Herpertz S., Loeber S. Personality traits and obesity: a systematic review. Obes. Rev. 2015; 16:32–63. doi: 10.1111/obr.12235.
  86. Palavras M. A., Hay Ph., Filho C. A. « Efficacy of Psychological Therapies in Reducing Weight and Binge Eating in People with Bulimia Nervosa and Binge Eating Disorder Who Are Overweight or Obese—A Critical Synthesis and Meta-Analyses, Nutrients. 2017 Mar; 9(3): 299.
  87. Chalasani N, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018; 67: 328-357.
  88. Mechanick J, Apovian C, Brethauer S, Timothy Garvey W, Joffe AM, Kim J, Kushner RF, Lindquist R, Pessah-Pollack R, Seger J, Urman RD, Adams S, Cleek JB, Correa R, Figaro MK, Flanders K, Grams J, Hurley DL, Kothari S, Seger MV, Still CD. Clinical Practice Guidelines for the Perioperative Nutrition, Metabolic, and Nonsurgical Support of Patients Undergoing Bariatric Procedures - 2019 Update: Cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Obesity (Silver Spring). 2020 Apr;28(4):O1-O58. doi: 10.1002/oby.22719. PMID: 32202076.
  89. Stoker D. Management of the bariatric surgery patient. Endocrinol Meatb Clin North Am 2003; 32: 437-457
  90. Herpertz S, Kielmann R, Wolf A. et al. Do psychosocial variables predict weight loss or mental health after obesity surgery? A systematic review. Obes Res 2004;12:1554-69
  91. Kalarchian M., Marcus M., Levine M. et al. Relationship of psychiatric disorders to 6-month outcomes after gastric bypass. Surg Obes Relat Dis 2008; 4: 544-9
  92. Tindle H., Omalu B., Courcoulas A. et al. Risk of suicide after long-term follow-up from bariatric surgery. Am J Med. 2010; 123: 1036-42.
  93. Sarwer D., Cohn N., Gibbons L. et al. Psychiatric diagnoses and psychiatric treatment among bariatric surgery candidates. Obes Surg 2004; 14: 1148-56.
  94. Van Hout G., Verschure S., Van Heck G. Psychosocial predictors of success following bariatric surgery. Obes Surg 2005; 15(4): 552-60
  95. Wadden T., Sarwer D. Behavioral Assessment of Candidates for Bariatric Surgery: A Patient-Oriented Approach. Obesity 2006; 14 (Suppl): 53S - 62S
  96. Geerts W., Pineo G., Heit J. et al. Prevention of venous thromboembolism: the seventh ACCP conference of antithrombotic and thrombolytic therapy. Chest 2004; 126 (3 Suppl): 338S-400S
  97. Fernandes SR, Meireles LC, Carrilho-Ribeiro L, Velosa J. The Role of Routine Upper Gastrointestinal Endoscopy Before Bariatric Surgery. Obes Surg. 2016 Sep;26(9):2105-2110. doi: 10.1007/s11695-016-2056-9.
  98. Knowler WC, Barrett-Connor E, Fowler SE, et al. Diabetes Prevention Program Research Group: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393–403.
  99. Blundell JE, Dulloo AG, Salvador J, et al. on behalf of the EASO SAB Working Group on BMI: Beyond BMI – phenotyping the obesities. Obes Facts 2014; 7: 322–328.
  100. Schwarz PE, Lindström J, Kissimova-Scarbeck K, et al. The European perspective of type 2 diabetes prevention: diabetes in Europe – prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project. Exp Clin Endocrinol Diabetes 2008; 116: 167–172.
  101. Hainer V, Toplak H, Mitrakou A: Treatment modalities of obesity: What fits whom? Diabetes Care 2008; 31(suppl 2):S269–S277.
  102. Sampsel S, May J: Assessment and management of obesity and comorbid conditions. Dis Manag 2007; 1: 252–265.
  103. Jensen MD, Ryan DH, Apovian CM, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Obesity Society: 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014; 129(suppl 2): S102–S138.
  104. World Health Organization: Obesity: Preventing and Managing the Global Epidemic. Report of a WHO Consultation (WHO Technical Report Series 894). Geneva, WHO, 1998. www.who.int/nutrition/publications/obesity/WHO_TRS_894/en/ (last accessed November 30, 2015).
  105. le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DCW, Van Gaal L, Ortiz RV, Wilding JPH, Skjøth TV, Manning LS, Pi-Sunyer X; SCALE Obesity Prediabetes NN8022-1839 Study Group. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017 Apr 8; 389(10077):1399-1409. doi: 10.1016/S0140-6736(17)30069-7.
  106. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocr Pract, 2016; 22(Suppl 3).
  107. Durrer Schutz D, Busetto L, Dicker D, Farpour-Lambert N, Pryke R, Toplak H, Widmer D, Yumuk V, Schutz Y. European Practical and Patient-Centred Guidelines for Adult Obesity Management in Primary Care. Obes Facts. 2019;12(1):40-66. doi: 10.1159/000496183. Epub 2019 Jan 23. PMID: 30673677; PMCID: PMC6465693.
  108. Shai I, Schwarzfuchs D, Henkin Y, et al, for the Dietary Intervention Randomized Controlled Trial (DIRECT) Group: Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008; 359:229–241.
  109. Dernini S, Berry EM: Mediterranean diet: from a healthy diet to a sustainable dietary pattern. Front Nutr 2015;2: 1–6.
  110. Estruch R, Ros E, Salas-Salvadó J, et al for the PREDIMED Study Investigators: Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013; 368: 1279–1290.
  111. Avenell A., Brown T., McGee M. et al. What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials. J Hum Nutr Diet 2004; 17: 317-35.
  112. Dansinger M.L., Gleason J.A., Griffith J.L. et al. Comparison of the Atkins, Ornish, Weight Watchers, and Zone Diets for Weight Loss and Heart Disease Risk ReductionA Randomized Trial. JAMA. 2005;293(1):43-53. doi:10.1001/jama.293.1.43.
  113. Ard JD, Lewis KH, Cohen SS, Rothberg AE, Coburn SL, Loper J, Matarese L, Pories WJ, Periman S. Differences in treatment response to a total diet replacement intervention versus a food-based intervention: A secondary analysis of the OPTIWIN trial. Obes Sci Pract. 2020:1-10. doi.org/10.1002/osp4.444.
  114. Roesler A, Marshall S, Rahimi-Ardabili H, Duve E, Abbott K, Blumfield M, Cassettari T, Fayet-Moore F. Choosing and following a very low calorie diet program in Australia: A quasi-mixed methods study to understand experiences, barriers, and facilitators in a self-initiated environment. Nutr Diet. 2020:1-16
  115. Ard J, Lewis K, Rothberg A, Auriemma A, Coburn SL, Cohen SS, Loper J, Matarese L, Periman S, Pories WJ. Effectiveness of a total meal replacement program (OPTIFAST® program) on weight loss: Results from the OPTIWIN study. Obesity. 2018; 27:22-29 doi: 10.1002/oby.22303
  116. Perugini M, Marczewska A, Araujo Torres K, Rasouli B, Nuijten M. OPTIFAST® meal replacement program for the treatment of obesity: A cost effectiveness assessment from the employer perspective in the USA. Congress abstract: ISPOR 2018, Baltimore, MD.
  117. Steven, S., et al., Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders. Diabetes Care, 2016. 39(5): p. 808-15
  118. Bischoff, S.C., et al., Multicenter evaluation of an interdisciplinary 52-week weight loss program for obesity with regard to body weight, comorbidities and quality of life--a prospective study. International Journal of Obesity, 2012. 36(4): p. 614-24
  119. Colles SL, Dixon JB, Marks P, Strauss BJ, O'Brien PE. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr. 2006 Aug;84(2):304-11. doi: 10.1093/ajcn/84.1.304. PMID: 16895876.
  120. Sharma M: Behavioural interventions for preventing and treating obesity in adults. Obes Rev 2007; 8: 441–449
  121. Lang A, Froelicher ES: Management of overweight and obesity in adults: behavioral intervention for long-term weight loss and maintenance. Eur J Cardiovasc Nurs 2006; 5: 102–114.
  122. Moffitt R, Haynes A, Mohr P: Treatment beliefs and preferences for psychological therapies for weight management. J Clin Psychol 2015; 71: 584–596.
  123. Willis LH, Slentz CA, Bateman LA, Shields AT, Piner LW, Bales CW, Houmard JA, Kraus WE: Effects of aerobic and/or resistance training on body mass and fat mass in overweight or obese adults. J Appl Physiol 2012; 113:1831–1837.
  124. Geliebter A, Christopher N, Ochner CN, Dambkowski CL, Hashim SA: Obesity-related hormones and metabolic risk factors: a randomized trial of diet plus either strength or aerobic training versus diet alone in overweight participants. J Diabetes Obes 2015; 1: 1–7.
  125. Poirier P, Després JP: Exercise in weight management of obesity. Cardiol Clin 2001; 19: 459–470.
  126. Chin S.-H., Kahathuduwa C. N., Binks M. Physical activity and obesity: what we know and what we need to know. Obesity Reviews. 17 (2016): 1226-1244.
  127. Stephens S.K., Cobiac L.J., Lennert Veerman. J. Improving diet and physical activity to reduce population prevalence of overweight and obesity: An overview of current evidence. Preventive Medicine 62 (2014): 167–178.
  128. Chu S-F, Liou T-H, Chen H-C, Huang S-W, Liao C-D. Relative Efficacy of Weight Management, Exercise, and Combined Treatment for Muscle Mass and Physical Sarcopenia Indices in Adults with Overweight or Obesity and Osteoarthritis: A Network Meta-Analysis of Randomized Controlled Trials.Nutrients. 2021; 13(6):1992.
  129. Pazzianotto-Forti EM, Moreno MA, Plater E, Baruki SBS, Rasera-Junior I, Reid WD. Impact of Physical Training Programs on Physical Fitness in People With Class II and III Obesity: A Systematic Review and Meta-Analysis. Phys Ther. 2020 Jun 23;100(6):963-978.
  130. Stankovic, M., Djodjevic, S., Hadzovic, M., Djordjevic, D., & Katanic, B. (2021). The Effects Of Physical Activity On Obesity Among The Population Of Different Ages: A Systematic Review. Journal of Anthropology of Sport and Physical Education, 5(3), 19-26.
  131. Kim KB, Kim K, Kim C, et al. Effects of Exercise on the Body Composition and Lipid Profile of Individuals with Obesity: A Systematic Review and Meta-Analysis. J Obes Metab Syndr. 2019;28(4):278-294
  132. Berezin L, Nagappa M, Poorzargar K, Saripella A, Ariaratnam J, Butris N, Englesakis M, Chung F. The effectiveness of positive airway pressure therapy in reducing postoperative adverse outcomes in surgical patients with obstructive sleep apnea: A systematic review and meta-analysis. J Clin Anesth. 2023 Feb;84:110993. doi: 10.1016/j.jclinane.2022.110993. Epub 2022 Nov 5. PMID: 36347195.
  133. Truby H, Edwards BA, Day K, O'Driscoll DM, Young A, Ghazi L, Bristow C, Roem K, Bonham MP, Murgia C, Haines TP, Hamilton GS. A 12-month weight loss intervention in adults with obstructive sleep apnoea: is timing important? A step wedge randomised trial. Eur J Clin Nutr. 2022 Dec;76(12):1762-1769. doi: 10.1038/s41430-022-01184-5. Epub 2022 Aug 4. PMID: 35927505; PMCID: PMC9708544.
  134. Rucker D., Padwal R., Li S. et al. Long term pharmacotherapy for obesity and overweight updated meta-analysis. British Medical Journal 2007; 335: 1194-1199.
  135. Avenell A., Broom J., Brown T. et al. Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 2004; 8: iii-iv, 1-182.
  136. Bray GA: Medical treatment of obesity: the past, the present and the future. Best Pract Res Clin Gastroenterol 2014; 28:665-684.
  137. Pucci A, Finer N: New medications for treatment of obesity: metabolic and cardiovascular effects. Can J Cardiol 2015; 31:142-152.
  138. Torgerson JS, Hauptman J, Boldrin MN, SjoћИstroћИm L: Xenical in the Prevention of Diabetes in Obese Subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004; 27:155-161.
  139. Toplak H, Ziegler O, Keller U, Hamann A, Godin C, Wittert G, Zanella MT, ZuћБnћГiga-Guajardo S, Van Gaal L: X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance. Diabetes Obes Metab 2005; 7:699-708.
  140. W.P.T. Jzmes Effect of sibutramine on weight maintenance after weight loss: a randomised trial. Lancet 2000; 356: 2119–25.
  141. Dedov et al. Body Weight Reduction Associated with the Sibutramine Treatment: Overall Results of the PRIMAVERA Primary Health Care Trial. Obes Facts 2018; 11:335–343.
  142. Аметов А.С., Пьяных О.П., Невольникова А.О. Современные возможности управления метаболическим здоровьем у пациентов с ожирением и нарушениями углеводного обмена // Эндокринология: новости, мнения, обучение. 2020. Т. 9, № 1. С. 17–26. doi: 10.33029/2304-9529-2020-9-1-17-26.
  143. Sari R. et al. Comparison of the effects of sibutramine versus sibutramine plus metformin in obese women //Clinical and experimental medicine. – 2010. – Т. 10. – №. 3. – С. 179-184.
  144. Pi-Sunyer X, Astrup A, Fujioka K, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med.2015;373(1):11-22. https://doi.org/10.1056/NEJMoa1411892.
  145. le Roux CW, Astrup A, Fujioka K, et al. 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial. Lancet. 2017; 389(10077):1399-1409. doi:10.1016/s0140-6736(17)30069-7.
  146. Blackman A, Foster GD, Zammit G, et al. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial. Int J Obes (Lond). 2016;40(8):1310-1319. doi:10.1038/ij o.2016.52
  147. Wadden TA, Hollander P, Klein S et al. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study. International Journal of Obesity (2013) 37, 1443-1451; doi:10.1038/ijo.2013.120
  148. Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med 2016; 375(4):311-22. DOI: 10.1056/NEJMoa1603827
  149. TA Wadden, P Hollander, S Klein et al. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study. International Journal of Obesity (2013) 37, 1443-1451; doi:10.1038/ijo.2013.120].
  150. P-Sunyer X, Astrup A, Fujioka K, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med.2015;373(1):11-22. https://doi.org/10.1056/NEJMoa1411892].
  151. Шабутдинова О. Р., Даутов А. Р., Самков А. А., Кононенко А. В., Саргалиев А. Ф., Давлетшин А. Р., Андресова П. А., Зарбеева К. Р., Торшхоева Д. А., Рахмонкулов У. А., Афанасьев А. А. Семаглутид – эффективность в снижении веса и побочные эффекты при применении по данным исследований sustain, pioneer, step // Пробл. эндокр.. 2023. №3.
  152. Kushner RF, Calanna S, Davies M, Dicker D, Garvey WT, Goldman B, Lingvay I, Thomsen M, Wadden TA, Wharton S, Wilding JPH, Rubino D. Semaglutide 2.4 mg for the Treatment of Obesity: Key Elements of the STEP Trials 1 to 5. Obesity (Silver Spring). 2020 Jun;28(6):1050-1061. doi: 10.1002/oby.22794. PMID: 32441473; PMCID: PMC7318657.
  153. Davies M, Færch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L, Rosenstock J, Shimomura I, Viljoen A, Wadden TA, Lingvay I; STEP 2 Study Group. Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021 Mar 13;397(10278):971-984. doi: 10.1016/S0140-6736(21)00213-0. Epub 2021 Mar 2. PMID: 33667417.
  154. Wharton S, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, Jódar E, Kandler K, Rigas G, Wadden TA, Garvey WT. Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight/obesity: STEP 5. Obesity (Silver Spring). 2023 Mar;31(3):703-715. doi: 10.1002/oby.23673. Epub 2023 Jan 18. PMID: 36655300.
  155. Amaro A, Skolnik NS, Sugimoto D. Cardiometabolic risk factors efficacy of semaglutide in the STEP program. Postgrad Med. 2022 Jan;134(sup1):18-27. doi: 10.1080/00325481.2022.2147325. PMID: 36691308.
  156. Marso Steven P., Bain Stephen C., Consoli Agostino, Eliaschewitz Freddy G., Jódar Esteban, Leiter Lawrence A., Lingvay Ildiko, Rosenstock Julio, Seufert Jochen, Warren Mark L., Woo Vincent, Hansen Oluf, Holst Anders G., Pettersson Jonas, Vilsbøll Tina. Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes. New England Journal of Medicine. 2016 Sep;375(19):1834–1844. doi: 10.1056/nejmoa1607141
  157. Morgante G, Massaro MG, Di Sabatino A, Cappelli V, De Leo V. Therapeutic approach for metabolic disorders and infertility in women with PCOS. Gynecol Endocrinol. 2017 Aug 29:1-6.
  158. Mahutte N, Kamga-Ngande C, Sharma A, Sylvestre C. Obesity and Reproduction. J Obstet Gynaecol Can. 2018 Jul;40(7):950-966.
  159. https://rae-org.ru/system/files/documents/pdf/d_2021.pdf
  160. Di Lorenzo N, Antoniou SA, Batterham RL, et al. Clinical practice guidelines of the European Association for Endoscopic Surgery (EAES) on bariatric surgery: update 2020 endorsed by IFSO-EC, EASO and ESPCOP. Surg Endosc. 2020 Jun;34(6):2332-2358. doi: 10.1007/s00464-020-07555-y. Epub 2020 Apr 23. PMID: 32328827; PMCID: PMC7214495.
  161. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric Surgery A Systematic Review and Meta-Analysis. JAMA. 2004;292(14):1724. doi: 10.1001/jama.292.14.1724.
  162. Buchwald H, Estok R, Fahrbach K, et al. Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis. The American Journal of Medicine. 2009;122(3):248-256.e245. doi: 10.1016/j.amjmed.2008.09.041.
  163. Lujan JA, Frutos MD, Hernandez Q et al (2004) Laparoscopic versus open gastric bypass in the treatment of morbid obesity: a randomized prospective study. Ann Surg 239(4):433–437
  164. Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I (2007) Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery 142(4):621–632
  165. Dolan K, Creighton L, Hopkins G, Fielding G: Laparoscopic gastric banding in morbidly obese adolescents. Obes Surg 2003; 13:101–104.
  166. Stanford A, Glascock JM, Eid GM, Kane T, Ford HR, Ikramuddin S, et al: laparoscopic Roux-en-Y gastric bypass in morbidly obese adolescents. J Pediatr Surg 2003; 38:430–433.
  167. Silberhummer GR, Miller K, Kriwanek S, Widhalm K, Pump A, Prager G: laparoscopic adjustable gastric banding in adolescents: the Austrian experience. Obes Surg 2006;16:1062–1067.
  168. Lemanu DP, Singh PP, Berridge K, et al. Randomized clinical trial of enhanced recovery versus standard care after laparoscopic sleeve gastrectomy.Br J Surg.2013;100:482–489. doi: 10.1002/bjs.9026.
  169. Awad S, Carter S, Purkayastha S, Hakky S, Moorthy K, Cousins J, Ahmed AR. Enhanced recovery after bariatric surgery (ERABS): clinical outcomes from a tertiary referral bariatric centre. Obes Surg. 2014 May;24(5):753-8. doi: 10.1007/s11695-013-1151-4. PMID: 24357126; PMCID: PMC3972428.
  170. Michele Carron, Francesco Zarantonello, Paola Tellaroli, Carlo Ori, Perioperative noninvasive ventilation in obese patients: a qualitative review and meta-analysis, Surgery for Obesity and Related Diseases, Volume 12, Issue 3, 2016, Pages 681-691,ISSN 1550-7289, https://doi.org/10.1016/j.soard.2015.12.013. (мета-анализ когортных исследований) УДД2
  171. Kong, W.T., Chopra, S., Kopf, M. et al. Perioperative Risks of Untreated Obstructive Sleep Apnea in the Bariatric Surgery Patient: a Retrospective Study. OBES SURG 26, 2886–2890 (2016). https://doi.org/10.1007/s11695-016-2203-3 (когортное сравнительное проспективное исследование) УДД3
  172. Kaw R, Pasupuleti V, Wayne Overby D et al (2014) Inferior vena cava filters and postoperative outcomes in patients undergoing bariatric surgery: a meta-analysis. Surg Obes Relat Dis. https:// doi.org/10.1016/j.soard.2014.04.008
  173. Morgan DJ, Ho KM. The anaesthetic assessment, management and risk factors of bariatric surgical patients requiring postoperative intensive care support: a state-wide, five-year cohort study. Anaesthesth Intensive Care 2016;44:237–44.
  174. Sørensen LT. Wound Healing and Infection in Surgery: The Clinical Impact of Smoking and Smoking Cessation: A Systematic Review and Meta-analysis. Arch Surg. 2012;147(4):373–383. doi:10.1001/archsurg.2012.5
  175. https://cr.minzdrav.gov.ru/recomend/290_2
  176. Stenberg E, Dos Reis Falcão LF, O'Kane M, Liem R, Pournaras DJ, Salminen P, Urman RD, Wadhwa A, Gustafsson UO, Thorell A. Guidelines for Perioperative Care in Bariatric Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update. World J Surg. 2022 Apr;46(4):729-751. doi: 10.1007/s00268-021-06394-9
  177. Сахарный диабет 2 типа у взрослых. Дедов И.И., Шестакова М.В., Майоров А.Ю. и соавт. Сахарный диабет. – 2020. – Т. 23, № S2. – С. 4-102. – DOI 10.14341/DM12507. -EDN YBRIMY.
  178. Houlden RL, Yen JL, Moore S. Effectiveness of an interprofessional glycemic optimization clinic on preoperative glycated hemoglobin levels for adult patients with type 2 diabetes undergoing bariatric surgery. Can J Diabetes 2018;42:514–9.
  179. Bray GA, Heisel WE, Afshin A, et al. The Science of Obesity Management: An Endocrine Society Scientific Statement. Endocr Rev. 2018;39(2):79-132. doi: https://doi.org/10.1210/er.2017-00253
  180. Aller EE, Larsen TM, Claus H, et al. Weight loss maintenance in overweight subjects on ad libitum diets with high or low protein content and glycemic index: the DIOGENES trial 12-month results. Int. J. Obes. (Lond.). 2014;38:1511-1517. doi: https://doi.org/10.1038/ijo.2014.52
  181. Varkevisser RDM, van Stralen MM, Kroeze W, et al. Determinants of weight loss maintenance: a systematic review. Obes Rev. 2019;20(2):171-211. doi: https://doi.org/10.1111/obr.12772
  182. Schoeller DA, Shay K, Kushner RF. et al. How much physical activity is needed to minimize weight gain in previously obese women? Am J Clin Nutr. 1997;66(3):551-556. doi: https://doi.org/10.1093/ajcn/66.3.551.
  183. Endevelt R, Ben-Assuli O, Klain E, Zelber-Sagi S. The role of dietician follow-up in the success of bariatric surgery. Surg Obes Relat Dis. 2013 Nov-Dec;9(6):963-8. doi: 10.1016/j.soard.2013.01.006. Epub 2013 Jan 23. PMID: 23499190.
  184. Endocrine and Nutritional Management of the Post-Bariatric Surgery Patient: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2010; 95: 4823-43
  185. Brolin R., Leung M. Survey of vitamin and mineral supplementation after gastric bypass and biliopancreatic diversion for morbid obesity. Obes Surg 1999; 9: 150-154
  186. Skroubis G., Sakellapoulos G., Pouggouras K. et al. Comparison of nutritional deficiencies after Roux-en-Y gastric bypass and after biliopancreatic diversion with Roux-en-Y gastric bypass. Obes Surg 2002; 12: 551-558
  187. Gasteyger C., Suter H., Gaillard R. et al. Nutritional deficiencies after Roux-en-Y gastric bypass for morbid obesity often cannot be prevented by standart multivitamin supplementation. Am J Clin Nutr 2008; 87: 1128-33
  188. Aasheim E., Hofso D., Hjelmesaeth J., Birkeland K., Bohmer T. Vitamin status in morbidly obese patients: a cross-sectional study. Am J Clin Nutr 2008; 87:362-9
  189. Li Z, Zhou X, Fu W. Vitamin D supplementation for the prevention of vitamin D deficiency after bariatric surgery: a systematic review and meta-analysis. Eur J Clin Nutr. 2018 Aug;72(8):1061-1070. doi: 10.1038/s41430-017-0059-9. Epub 2017 Dec 29. PMID: 29288249.
  190. O'Kane M, Parretti HM, Pinkney J, Welbourn R, Hughes CA, Mok J, Walker N, Thomas D, Devin J, Coulman KD, Pinnock G, Batterham RL, Mahawar KK, Sharma M, Blakemore AI, McMillan I, Barth JH. British Obesity and Metabolic Surgery Society Guidelines on perioperative and postoperative biochemical monitoring and micronutrient replacement for patients undergoing bariatric surgery-2020 update. Obes Rev. 2020 Nov;21(11):e13087. doi: 10.1111/obr.13087. Epub 2020 Aug 2. PMID: 32743907; PMCID: PMC7583474.
  191. Busetto L, Dicker D, Azran C, Batterham RL, Farpour-Lambert N, Fried M, Hjelmesæth J, Kinzl J, Leitner DR, Makaronidis JM, Schindler K, Toplak H, Yumuk V. Practical Recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management. Obes Facts. 2017;10(6):597-632. doi: 10.1159/000481825. Epub 2017 Dec 6. PMID: 29207379; PMCID: PMC5836195.
  192. Weimann A, Braga M, Carli F, Higashiguchi T, Hübner M, Klek S, Laviano A, Ljungqvist O, Lobo DN, Martindale RG, Waitzberg D, Bischoff SC, Singer P. ESPEN practical guideline: Clinical nutrition in surgery. Clin Nutr. 2021 Jul;40(7):4745-4761. doi: 10.1016/j.clnu.2021.03.031. Epub 2021 Apr 19. PMID: 34242915.
  193. Carmel R. How I treat cobalamin (vitamin B12) deficiency. Blood 2008;112:2214–21. https://doi.org/10.1182/blood-2008-03-040253.
  194. 18.Devalia V, Hamilton MS, Molloy AM. Guidelines for the diagnosis and treatment of cobalamin and folate disorders. Br J Haematol 2014;166:496–513. https://doi.org/10.1111/bjh.12959.
  195. Vidal-Alaball J, Butler C, Cannings-John R, Goringe A, Hood K, McCaddon A, et al. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev 2005. https://doi.org/10.1002/14651858.CD004655.pub2.
  196. Magouliotis DE, Tasiopoulou VS, Svokos AA, et al. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: an updated systematic review and meta-analysis. Obes Surg. 2017 doi: 10.1007/s11695-017-2924-y.

Для продолжения работы требуется Registration
На предыдущую страницу

Предыдущая страница

Следующая страница

На следующую страницу
Список литературы
На предыдущую главу Предыдущая глава
оглавление
Следующая глава На следующую главу

Table of contents

Данный блок поддерживает скрол*